Tirzepatide

Tirzepatide (TR100 – 100MG) by GX Peptide Supply is a premier synthetic peptide designed to activate both the GIP and GLP-1 inkretin receptors. By targeting two distinct metabolic pathways simultaneously, Tirzepatide is a primary subject of interest for researchers investigating multi-receptor synergy in the treatment of metabolic dysfunction and obesity.

Key Research Properties:

• Dual Receptor Synergy: Investigated for its ability to mimic the physiological actions of both GIP and GLP-1, potentially offering a more robust metabolic profile than single-receptor agonists.

• Glucose Homeostasis: Targeted in studies examining glucose-dependent insulin secretion and the suppression of inappropriate glucagon release.

• Metabolic Efficiency: Frequently utilized in laboratory models exploring enhanced lipid metabolism, weight management mechanisms, and the reduction of adipose tissue.

• Extended Half-Life: Featuring specific modifications that enable sustained biological activity, allowing for the observation of long-term metabolic shifts in research subjects.

Product Specifications:

• Product Code: TR100.

• Concentration: 100mg per vial.

• Format: Lyophilized (freeze-dried) powder for maximum molecular stability and peak activity upon reconstitution.

• Analytical Purity: Manufactured by GX Peptide Supply to meet rigorous analytical standards, ensuring sequence accuracy and the absence of cross-contaminants.

Storage & Handling Guidelines:

• Temperature: Store non-reconstituted vials at -20°C for optimal long-term shelf life.

• Light Protection: Provided in specialized light-resistant vials to prevent photochemical degradation.

• Reconstitution: For best results, use sterile laboratory-grade solvents under aseptic conditions; avoid mechanical stress or vigorous agitation of the solution.